Zymeworks (ZYME) Assets (2021 - 2026)

Zymeworks has disclosed Assets across 6 years of filings, most recently posting $478.2 million for Q1 2026.

• Assets for Q1 2026 came in at $478.2 million, up 12.38% year-over-year; the trailing twelve-month figure through Mar 2026 was $478.2 million (up 12.38% YoY), and the FY2025 annual result was $346.5 million, down 25.17% from the prior year.
• Assets came in at $478.2 million for Q1 2026 at Zymeworks, up from $346.5 million in the prior quarter.
• In the past five years, Assets ranged from a high of $648.7 million in Q4 2022 to a low of $300.3 million in Q3 2022.
• The 5-year median for Assets is $487.2 million (2024), against an average of $491.0 million.
• Across the five-year window, Assets soared 85.29% in 2023 and decreased 25.17% in 2025, its largest moves.
• Zymeworks' Assets stood at $648.7 million in 2022, then declined by 10.46% to $580.9 million in 2023, then declined by 20.28% to $463.1 million in 2024, then fell by 25.17% to $346.5 million in 2025, then surged by 38.0% to $478.2 million in 2026.
• The last three Assets figures came in at $478.2 million (Q1 2026), $346.5 million (Q4 2025), and $397.3 million (Q3 2025), per Business Quant data.